Apogee director granted 7,657 stock options
Apogee Therapeutics director Lisa Bollinger received a stock option grant for 7,657 shares of common stock on June 9, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Apogee Therapeutics director Lisa Bollinger received a stock option grant for 7,657 shares of common stock on June 9, 2026. The option has an exercise price of $85.00 per share and expires on June 9, 2036. All 7,657 options will vest on the one-year anniversary of the grant date, contingent on her continued service, and represent her total option holdings reported in this filing.
Insider Trade Summary
Grant/Award: 7,657 shares
Grant/Award
1 txn
Insider
Bollinger Lisa
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 7,657 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 7,657 contracts (Direct)
Footnotes (1)
- F1. This option represents the right to purchase 7,657 shares of the Issuer's common stock and will vest on the one-year anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer on such vesting date.
Key Figures
Options granted: 7,657 options
Exercise price: $85.00 per share
Expiration date: June 9, 2036
+2 more
5 metrics
Options granted
7,657 options
Stock option grant on June 9, 2026
Exercise price
$85.00 per share
Strike price for stock options
Expiration date
June 9, 2036
Option term end
Underlying shares
7,657 shares
Common stock underlying option grant
Post-grant option holdings
7,657 options
Total options held after transaction
Key Terms
Stock Option (Right to Buy), exercise price, expiration date, vest, +1 more
5 terms
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
exercise price financial
"conversion_or_exercise_price: 85.0000"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: 2036-06-09T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
vest financial
"will vest on the one-year anniversary of the grant date"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
grant, award, or other acquisition financial
"transaction_code_description: Grant, award, or other acquisition"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Apogee Therapeutics (APGE) report for Lisa Bollinger?
Apogee Therapeutics reported that director Lisa Bollinger received a stock option grant for 7,657 shares. The options are exercisable into common stock at a fixed price and represent a compensation-related award, not an open-market purchase or sale.
What is the exercise price of Lisa Bollinger’s new Apogee Therapeutics (APGE) options?
The granted stock options carry an exercise price of $85.00 per share. This means Bollinger can buy Apogee Therapeutics common stock at $85.00 once the options vest, regardless of the market price at that time.
When do Lisa Bollinger’s Apogee Therapeutics (APGE) stock options vest?
The 7,657 stock options granted to Lisa Bollinger vest on the one-year anniversary of the June 9, 2026 grant date. Vesting is conditioned on her continued service with Apogee Therapeutics through that anniversary date.
When do Lisa Bollinger’s Apogee Therapeutics (APGE) options expire?
Lisa Bollinger’s stock options expire on June 9, 2036. After that expiration date, any unexercised options become worthless and can no longer be used to purchase Apogee Therapeutics common shares at the $85.00 exercise price.
How many Apogee Therapeutics (APGE) options does Lisa Bollinger hold after this grant?
Following this grant, Lisa Bollinger holds 7,657 stock options according to the Form 4. These options are all from this single grant and are subject to a one-year vesting requirement tied to continued service.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates